Key result
Cross-subject autoregressive models yield ~96% clinically acceptable glucose predictions, rivaling individually tuned models.
Why the study?
Do data-driven autoregressive models accurately predict glucose levels in patients with type 1 diabetes mellitus?
Observational (n=9)
Do data-driven autoregressive models accurately predict glucose levels in patients with type 1 diabetes mellitus?
Data-driven autoregressive models can provide sufficiently accurate 30-minute predictions of glucose levels in type 1 diabetes, even when using portable cross-subject models.
Answers are grounded in this paper and cite their sources.
May support portable glucose forecasting in T1DM without individual tuning; hypothesis-generating and should not yet change practice.
BACKGROUND: Recent developments and expected near-future improvements in continuous glucose monitoring (CGM) devices provide opportunities to couple them with mathematical forecasting models to produce predictive monitoring systems for early, proactive glycemia management of diabetes mellitus patients before glucose levels drift to undesirable levels. This article assesses the feasibility of data-driven models to serve as the forecasting engine of predictive monitoring systems. METHODS: We investigated the capabilities of data-driven autoregressive (AR) models to (1) capture the correlations in glucose time-series data, (2) make accurate predictions as a function of prediction horizon, and (3) be made portable from individual to individual without any need for model tuning. The investigation is performed by employing CGM data from nine type 1 diabetic subjects collected over a continuous 5-day period. RESULTS: With CGM data serving as the gold standard, AR model-based predictions of glucose levels assessed over nine subjects with Clarke error grid analysis indicated that, for a 30-minute prediction horizon, individually tuned models yield 97.6 to 100.0% of data in the clinically acceptable zones A and B, whereas cross-subject, portable models yield 95.8 to 99.7% of data in zones A and B. CONCLUSIONS: This study shows that, for a 30-minute prediction horizon, data-driven AR models provide sufficiently-accurate and clinically-acceptable estimates of glucose levels for timely, proactive therapy and should be considered as the modeling engine for predictive monitoring of patients with type 1 diabetes mellitus. It also suggests that AR models can be made portable from individual to individual with minor performance penalties, while greatly reducing the burden associated with model tuning and data collection for model development.
No takes yet. Share an insight, caveat, or question.
Reifman et al. (2007) conducted an observational in Type 1 diabetes mellitus (n=9). Data-driven autoregressive (AR) models vs. Individually tuned models was evaluated on Percentage of data in clinically acceptable zones A and B on Clarke error grid analysis for a 30-minute prediction horizon. Cross-subject portable autoregressive models yielded 95.8-99.7% of glucose predictions in clinically acceptable zones A and B for a 30-minute horizon, vs 97.6-100.0% for individually tuned models.
Synapse has enriched 10 related papers. Consider them for comparative context: